The New York Times (1/20, D1, Harris) reports on the front page of its Science Times section that “experts and lawmakers are growing more and more concerned that the nation is far too reliant on medicine from abroad, and they are calling for a law that would require that certain drugs be made or stockpiled in the United States.” Senator Sherrod Brown said, “The lack of regulation around outsourcing is a blind spot that leaves room for supply disruptions, counterfeit medicines, even bioterrorism.” One of the reasons pharmaceutical plants have moved “overseas is that the F.D.A. inspects domestic plants far more often than foreign ones, making production more expensive in the United States.”
From the American Association for Justice news release.
